Evidence map›Paper›PMID 27213349›Full record

ArticleInternational journal of molecular sciences2016

Antibacterial Activity of Ciprofloxacin-Encapsulated Cockle Shells Calcium Carbonate (Aragonite) Nanoparticles and Its Biocompatability in Macrophage J774A.1.

Tijani Isa, Zuki Abu Bakar Zakaria, Yaya Rukayadi, Mohd Noor Mohd Hezmee, Alhaji Zubair Jaji, Mustapha Umar Imam, Nahidah Ibrahim Hammadi, Saffanah Khuder Mahmood

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tijani IsaLaboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia. tjelyakub@gmail.com.
Zuki Abu Bakar ZakariaLaboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia. zuki@upm.edu.my.
Yaya RukayadiFaculty of Food Science and Technology and Laboratory of Natural Product, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia. yaya_rukayadi@upm.edu.my.
Mohd Noor Mohd HezmeeLaboratory of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia. hezmee@upm.edu.my.
Alhaji Zubair JajiFaculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia. jajidvm@yahoo.com.
Mustapha Umar ImamLaboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia. mustyimam@gmail.com.
Nahidah Ibrahim HammadiFaculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia. naheda_ibrahem@yahoo.com.
Saffanah Khuder MahmoodFaculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia. saffanh.jeber@gmail.com.
Universiti Putra Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of nanoparticle delivery systems to enhance intracellular penetration of antibiotics and their retention time is becoming popular. The challenge, however, is that the interaction of nanoparticles with biological systems at the cellular level must be established prior to biomedical applications. Ciprofloxacin-cockle shells-derived calcium carbonate (aragonite) nanoparticles (C-CSCCAN) were developed and characterized. Antibacterial activity was determined using a modified disc diffusion protocol on Salmonella Typhimurium (S. Typhimurium). Biocompatibilittes with macrophage were evaluated using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and 5-Bromo-2'-deoxyuridine (BrdU) assays. Transcriptional regulation of interleukin 1 beta (IL-1β) was determined using reverse transcriptase-polymerase chain reaction (RT-PCR). C-CSCCAN were spherical in shape, with particle sizes ranging from 11.93 to 22.12 nm. Encapsulation efficiency (EE) and loading content (LC) were 99.5% and 5.9%, respectively, with negative ζ potential. X-ray diffraction patterns revealed strong crystallizations and purity in the formulations. The mean diameter of inhibition zone was 18.6 ± 0.5 mm, which was better than ciprofloxacin alone (11.7 ± 0.9 mm). Study of biocompatability established the cytocompatability of the delivery system without upregulation of IL-1β. The results indicated that ciprofloxacin-nanoparticles enhanced the antibacterial efficacy of the antibiotic, and could act as a suitable delivery system against intracellular infections.

Indexed as

Calcium CarbonateCiprofloxacinDrug CarriersMaterials TestingAnimalsCell LineMacrophagesMiceNanoparticlesCalcium CarbonateCiprofloxacinDrug Carriersantimicrobial resistancecalcium carbonate (aragonite) nanoparticlesciprofloxacinintracellular infectionproinflammatory cytokine

Identifiers

PMID27213349
PMCPMC4881535
OpenAlexW2404870875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.